WELL Health Technologies (TSE:WELL - Free Report) had its price objective lifted by Royal Bank of Canada from C$7.00 to C$8.50 in a research report sent to investors on Tuesday,BayStreet.CA reports.
A number of other research firms have also issued reports on WELL. Ventum Financial cut their price target on WELL Health Technologies from C$8.00 to C$7.00 and set a "buy" rating on the stock in a research note on Tuesday, October 29th. CIBC increased their target price on WELL Health Technologies from C$5.25 to C$7.00 in a report on Friday, December 13th. Raymond James increased their target price on WELL Health Technologies from C$10.00 to C$11.00 in a research report on Tuesday, December 17th. Haywood Securities raised their target price on WELL Health Technologies from C$8.00 to C$10.00 in a research note on Friday, December 13th. Finally, Scotiabank raised their target price on shares of WELL Health Technologies from C$6.00 to C$7.00 in a report on Monday, December 16th.
View Our Latest Stock Report on WELL
WELL Health Technologies Stock Performance
Shares of WELL traded up C$0.31 during mid-day trading on Tuesday, reaching C$7.26. The company had a trading volume of 2,535,963 shares, compared to its average volume of 1,390,781. WELL Health Technologies has a 52-week low of C$3.41 and a 52-week high of C$7.36. The company has a quick ratio of 1.02, a current ratio of 1.25 and a debt-to-equity ratio of 41.57. The stock has a market capitalization of C$1.81 billion, a P/E ratio of 12.74, a PEG ratio of -1.93 and a beta of 1.20. The stock has a 50 day moving average of C$5.94 and a two-hundred day moving average of C$5.03.
WELL Health Technologies Company Profile
(
Get Free Report)
WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.
Read More
Before you consider WELL Health Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and WELL Health Technologies wasn't on the list.
While WELL Health Technologies currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.